Showing 13,781 - 13,800 results of 14,135 for search '(( 50 ((mg decrease) OR (we decrease)) ) OR ( 59 ((mean decrease) OR (a decrease)) ))', query time: 0.60s Refine Results
  1. 13781

    Image_1_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.JPEG by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  2. 13782

    Image_2_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.JPEG by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  3. 13783

    Image_2_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.JPEG by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  4. 13784

    Table_1_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.DOCX by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  5. 13785

    Table_1_Construction of the Ohio Children's Opportunity Index.DOCX by Naleef Fareed (8995952)

    Published 2022
    “…We found R-squared values > 0.50 between the OCOI and the national Child Opportunity Index scores. …”
  6. 13786

    Table_3_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF by Mads N. Thomsen (13270053)

    Published 2022
    “…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
  7. 13787

    Image_1_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF by Mads N. Thomsen (13270053)

    Published 2022
    “…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
  8. 13788

    Table_1_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF by Mads N. Thomsen (13270053)

    Published 2022
    “…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
  9. 13789

    Table_2_Weight loss improves β-cell function independently of dietary carbohydrate restriction in people with type 2 diabetes: A 6-week randomized controlled trial.PDF by Mads N. Thomsen (13270053)

    Published 2022
    “…</p>Methods<p>In order to determine the additional effect of carbohydrate restriction in addition to a fixed body weight loss, we randomly assigned 72 adults with T2D and obesity (mean ± SD HbA<sub>1c</sub> 7.4 ± 0.7%, BMI 33 ± 5 kg/m<sup>2</sup>) to a carbohydrate-reduced high-protein diet (CRHP; energy percent from carbohydrate/protein/fat: 30/30/40) or an isocaloric conventional diabetes diet (CD; 50/17/33) for 6 weeks. …”
  10. 13790

    Image_2_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpeg by Jae Hong Choi (3339120)

    Published 2022
    “…Considering the change in antibody levels over time, both nAb and S-IgG levels at visit 4 decreased compared with the corresponding levels at visit 3. …”
  11. 13791

    Table 1_The impact of comorbidities on surgical outcome and mortality in minimally invasive mitral valve surgery: a systematic review.docx by Vanessa I. T. Zwaans (22163257)

    Published 2025
    “…Left atrial (LA) diameter decreased significantly from 50.37 mm preoperatively to 40.41%mm postoperatively (p < 0.001), LVDD was significantly reduced after MIMVS (p < 0.001). …”
  12. 13792

    Tuning of Msn2 expression in rapidly growing cells. by Michal Chapal (7961111)

    Published 2019
    “…(C–E) Msn2 expression increases stress protection but slows growth in the absence of stress: we generated a library of 50 strains with <i>MSN4</i> deletion and Msn2-YFP expressed under different synthetic promoters (from Keren and colleagues [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000289#pbio.3000289.ref032" target="_blank">32</a>]), spanning a range of expression values (C, Materials and Methods). …”
  13. 13793

    Image_1_Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.jpg by Jae Hong Choi (3339120)

    Published 2022
    “…Considering the change in antibody levels over time, both nAb and S-IgG levels at visit 4 decreased compared with the corresponding levels at visit 3. …”
  14. 13794

    Understanding the determinants of maternal mortality: An observational study using the Indonesian Population Census by Lisa Cameron (636941)

    Published 2019
    “…</p><p>Conclusion</p><p>Indonesia has employed a strategy over the past several decades of increasing the supply of midwives as a way of decreasing maternal mortality. …”
  15. 13795

    Replication package for "Measuring trade costs and analyzing the determinants of trade growth between Cambodia and major trading partners: 1993-2019" by Borin Keo (20919743)

    Published 2025
    “…<p dir="ltr"><b>Background: </b>Like in many other least-developed countries (LDCs), high trade costs have long been a major barrier to Cambodia's trade integration. …”
  16. 13796

    Data_Sheet_1_The Effect of Sex and Wealth on Population Attributable Risk Factors for Dementia in South Africa.docx by Kirsten Bobrow (5733674)

    Published 2021
    “…<p>Background and Aims: South Africa is a middle-income country with high levels of income inequality and a rapidly aging population and increasing dementia prevalence. …”
  17. 13797

    Data_Sheet_1_Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study.pdf by M. Liset Rietman (6760496)

    Published 2019
    “…</p><p>Methods: The Doetinchem Cohort Study is a longitudinal population-based study that started in 1987–1991 in men and women aged 20–59 years, with follow-up examinations every 5 years. …”
  18. 13798

    Image_6_Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.TIF by Marcial Sebode (3207339)

    Published 2019
    “…Intrahepatic type II NKT cells of AIH patients had a different cytokine profile than healthy subjects with an increased frequency of TNFα (77.8% vs. 59.1%, p < 0.05), decreased IFNγ (32.7% vs. 63.0%, p < 0.05) and a complete lack of IL-4 expressing cells (0% vs. 2.1%, p < 0.05). …”
  19. 13799

    Image_3_Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.TIF by Marcial Sebode (3207339)

    Published 2019
    “…Intrahepatic type II NKT cells of AIH patients had a different cytokine profile than healthy subjects with an increased frequency of TNFα (77.8% vs. 59.1%, p < 0.05), decreased IFNγ (32.7% vs. 63.0%, p < 0.05) and a complete lack of IL-4 expressing cells (0% vs. 2.1%, p < 0.05). …”
  20. 13800

    Image_2_Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis.TIF by Marcial Sebode (3207339)

    Published 2019
    “…Intrahepatic type II NKT cells of AIH patients had a different cytokine profile than healthy subjects with an increased frequency of TNFα (77.8% vs. 59.1%, p < 0.05), decreased IFNγ (32.7% vs. 63.0%, p < 0.05) and a complete lack of IL-4 expressing cells (0% vs. 2.1%, p < 0.05). …”